Related Experiment Videos
p53 and MDM2 expression in oral squamous cell carcinoma
T Matsumura1, Y Yoshihama, T Kimura
1Department of Oral and Maxillofacial Surgery II, Okayama University Dental School, Japan.
Oncology
|July 1, 1996
Summary
The p53 tumor suppressor gene is often altered in oral cancers. This study found that MDM2 protein may cause p53 dysfunction in oral squamous cell carcinoma, suggesting a new therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p53 tumor suppressor gene is frequently mutated in human cancers, including oral squamous cell carcinoma (OSCC) and its precancerous lesions.
- MDM2 (murine double minute-2) is a proto-oncogene that can negatively regulate p53 activity.
- Understanding the interplay between p53 and MDM2 is crucial for OSCC pathogenesis.
Purpose of the Study:
- To determine the incidence of MDM2 protein expression in OSCC and precancerous lesions.
- To investigate the relationship between MDM2 expression and p53 protein levels/activity in these oral conditions.
- To explore MDM2 as a potential mechanism for p53 dysfunction in OSCC.
Main Methods:
- Immunohistochemical analysis was used to detect p53 and MDM2 protein overexpression.
- Analysis was performed on samples of oral squamous cell carcinoma and precancerous lesions.
- p53 gene mutation status was assessed in carcinoma cases.
Main Results:
- Overexpression of p53 protein was observed in 52% of OSCC cases.
- MDM2 protein overexpression was detected in 40% of OSCC cases.
- p53 gene mutations were identified in 31% of OSCC cases, and were absent in normal oral epithelium.
Conclusions:
- MDM2 protein overexpression is present in a significant proportion of OSCC.
- MDM2 may represent an alternative mechanism for p53 protein dysfunction in OSCC, independent of direct p53 mutation.
- Targeting MDM2 could be a potential therapeutic strategy for oral squamous cell carcinoma.